Discover best practices and common pitfalls for sponsors and vendors in RTSM. Learn how to optimize your study by leveraging vendor expertise, avoiding delays, and embracing innovation for better outcomes.

Since the late 1990s, IRT has been central to clinical supply management. Modern decentralized trials now bring the supply chain into patient experience. This whitepaper explores direct-to-patient models and their pros and cons.

Data is the single most important thing in a clinical trial. Leverage the power of clinical trial data with effective utilization and access in a changing regulatory landscape.

We analyzed web traffic, content downloads, social media engagement, webinar attendance, and other metrics to determine the themes that caught your attention and aligned with broader industry trends.

A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.

A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.

Signant’s SmartSignals® RTSM solution helped an innovative biopharmaceutical company secure an FDA Orphan Drug designation for its cardiomyopathy drug.

Explore how these integrated solutions helped an emerging biopharma to implement a plan for study build and migration with minimal disruption to sites.

Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.